Eriksen Jason L, Janus Christopher G
Department of Neuroscience, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Behav Genet. 2007 Jan;37(1):79-100. doi: 10.1007/s10519-006-9118-z. Epub 2006 Oct 28.
Within the past decade, our understanding of the pathogenic mechanisms in Alzheimer's disease (AD) has dramatically advanced because of the development of transgenic mouse models that recapitulate the key pathological and behavioral phenotypes of the disease. These mouse models have allowed investigators to test detailed questions about how pathology develops and to evaluate potential therapeutic approaches that could slow down the development of this disease. In this review, we discuss the status of transgenic mouse models and review the complex relationship between pathology and behavior in the development of neuropathological syndromes in AD.
在过去十年中,由于转基因小鼠模型的发展,我们对阿尔茨海默病(AD)致病机制的理解有了显著进展,这些模型概括了该疾病的关键病理和行为表型。这些小鼠模型使研究人员能够测试关于病理如何发展的详细问题,并评估可能减缓该疾病发展的潜在治疗方法。在这篇综述中,我们讨论转基因小鼠模型的现状,并回顾AD神经病理综合征发展过程中病理与行为之间的复杂关系。